Our findings showed that IMP3 protein expression was also significantly associated with IDH1 wild-type phenotype and MGMT unmethylated phenotype in HGG gliomas and we can speculate that the expression of IMP3 in cases without IDH1 mutations and MGMT methylation confirms the role of the former as a negative prognostic marker. The gene discussed is IDH1; the disease is central nervous system cancer.